99 | 0 | 126 |
下载次数 | 被引频次 | 阅读次数 |
目的:对桃红四物汤合瓜蒌薤白半夏汤治疗不稳定型心绞痛(UAP)痰瘀互结证临床观察进行探讨。方法:回顾选取2021年1月~2023年12月大庆市人民医院中医科收治的UAP患者共89例,辨证为痰瘀互结证,按照不同给药方法分为联合组48例及对照组41例。两组均以常规西药进行治疗,联合组加用桃红四物汤合瓜蒌薤白半夏汤进行治疗,比较两组治疗前后中医症候积分、心绞痛发作情况、血液流变学[全血高切、低切黏度、血小板聚集率、血浆黏度、红细胞比容]、炎症指标[白细胞介素-18(IL-18)、人基质金属蛋白酶(MMP-9)、细胞间黏附分子-1(ICAM-1)、同型半胱氨酸(Hcy)],并比较两组临床疗效及硝酸甘油减停率。结果:两组治疗后中医症候积分、心绞痛发作次数、发作持续时间相较治疗前均有降低,且联合组下降幅度更大(P<0.05);两组治疗后血液流变学均低于治疗前,且联合组低于对照组(P<0.05);两组治疗后血清Hcy、MMP-9、IL-18及ICAM-1水平均有下降,且联合组下降幅度更大(P<0.05);联合组临床疗效及硝酸甘油减停率均高于对照组(P<0.05)。结论:桃红四物汤合瓜蒌薤白半夏汤可有效改善UAP患者血液流变学指标和炎症指标,缓解心绞痛症状,临床疗效确切。
Abstract:Objective: To discuss the clinical observation of Taohong Siwu Decoction combined with Gualou Xiebai Banxia Decoction in the treatment of unstable angina pectoris(UAP) syndrome of phlegm-stasis interformation. Methods: A total of 89UAP patients admitted to the Department of Traditional Chinese Medicine of Daqing People's Hospital from January 2021to December 2023were retrospectively selected, and they were dialectical as phlegm and blood stasis interformation syndrome. According to different administration methods, they were divided into a combination group(48cases) and a control group(41cases). Both groups were treated with conventional western medicine, and the combined group was treated with Gualou Xiebai Banxia Decoction and Taohong Siwu decoction. TCM symptom score, angina pectoris attack, hemorheology [whole blood high incision viscosity, low incision viscosity, platelet aggregation rate, plasma viscosity, erythrocyte specific volume],inflammatory index [interleukin-18(IL-18),human matrix metalloproteinase(MMP-9),intercellular adhesion molecule-1(ICAM-1),homocysteine] were compared between the two groups before and after treatment(Hcy)],and compared the clinical efficacy and the reduction rate of nitroglycerin between the two groups. Results: The scores of TCM symptoms, the frequency of angina pectoris attacks and the duration of angina pectoris attacks were decreased after treatment in both groups, and the decrease was greater in the combined group(P<0.05). The hemorheology of the two groups after treatment was lower than that before treatment, and the combined group was lower than the control group(P<0.05). The serum levels of Hcy, MMP-9,IL-18and ICAM-1in 2groups were decreased after treatment, and the decrease was greater in the combined group(P<0.05). The clinical efficacy and the reduction rate of nitroglycerin in combination group were higher than those in control group(P<0.05). Conclusion: Gualou Xiebai Banxia Decoction and Taohong Siwu decoction can effectively improve the hemorheology index and inflammation index of UAP patients, relieve the symptoms of angina pectoris, and the clinical effect is accurate
[1] Fang J Y,Zhang X L.Effect of various doses of rosuvastatin in the treatment of elderly patients with unstable angina pectoris[J].Am J Transl Res,2022,14(1):594-602.
[2] 王亮,周渝.不稳定心绞痛MSCT冠脉造影、动态心电图表现及其诊断价值研究[J].中国CT和MRI杂志,2021,19(10):67-69.
[3] Tjora H L,Steiro O T,Lang?rgen J,et al.Aiming towards evidence based interpretation of cardiac biomarkers in patients presenting with chest painthe WESTCOR study:study design[J].Scand Cardiovasc J,2019,53(5):280-285.
[4] Khan H,Kanny O,Syed M H,et al.Aspirin resistance in vascular disease:a review highlighting the critical need for improved point of-care testing and personalized therapy[J].Int J Mol Sci,2022,23(19):11317.
[5] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.非ST段抬高型急性冠状动脉综合征诊断和治疗指南(2016)[J].中华心血管病杂志,2017,45(5):359-376.
[6] 中国医师协会中西医结合医师分会,中国中西医结合学会心血管病专业委员会,中国中西医结合学会重症医学专业委员会,等.急性心肌梗死中西医结合诊疗指南[J].中国中西医结合杂志,2018,38(3):272-284.
[7] 庄逸洋,卢茵茵,李荣,等.通窍救心油舌下给药对不稳定性心绞痛气滞血瘀证患者生活质量的影响[J].中国全科医学,2019,22(16):1983-1989.
[8] 张超,关敬树,姚成增,等.心痛宁颗粒联合常规治疗对气虚痰瘀型稳定性心绞痛患者的临床疗效[J].中成药,2021,43(11):3014-3018.
[9] Akbar MR,Pranata R,Wibowo A,et al.The association between triglyceride-glucose index and major adverse cardiovascular events in patients with acute coronary syndrome-dose-response meta-analysis[J].Nutr Metab Cardiovasc Dis,2021,31(11):3024-3030.
[10] Hasbani N R,Ligthart S,Brown M R,et al.American Heart Association's life's simple 7:lifestyle recommendations,polygenic risk,and lifetime risk of coronary heart disease[J].Circulation,2022,145(11):808-818.
[11] 任莹,杨蕾,赵平凡,等.益气复脉通络方加减对不稳定型心绞痛心肌酶谱、sICAM-1和MMPs-9水平影响[J].中华中医药学刊,2019,37(11):2719-2722.
[12] 朱瑞,韩影,何勇,等.瓜蒌薤白半夏汤合血府逐瘀汤加减联合西医治疗胸痹心痛临床研究[J].四川中医,2020,38(11):95-98.
[13] 俸道荣,韦斌,曲楠,等.瓜蒌薤白半夏汤合小建中汤加减治疗阳虚痰阻型稳定型心绞痛的临床研究[J].中华中医药杂志,2022,37(02):1184-1187.
[14] 唐偲,邓鑫,方芳,等.桃红四物汤对骨质疏松性股骨干骨折术后骨折愈合、炎性因子及预后的影响研究[J].中国中医基础医学杂志,2020,26(05):651-654.
[15] 何信用,王俊岩,宋囡,等.二陈汤合桃红四物汤调控p53/SLC7A11介导的氧化损伤及铁死亡抗动脉粥样硬化的作用及机制研究[J].中华中医药杂志,2020,35(05):2344-2348.
[16] 凌小艳,韩平,崔晓华.桃红四物汤合二陈汤加减治疗老年慢性阻塞性肺疾病的临床分析[J].时珍国医国药,2022,33(07):1678-1681.
[17] 沈仲琪,刘明阳,董振飞.基于网络药理学及分子对接探寻仲景瓜蒌薤白半夏汤治疗冠心病的活性成分及作用机制[J].时珍国医国药,2022,33(10):2550-2553.
[18] 陈明军,严家龙,林志远.养心止痛汤治疗老年不稳定型心绞痛的临床分析[J].四川中医,2023,41(10):95-99.
基本信息:
DOI:
中图分类号:R259
引用信息:
[1]时小明,唐家发,张驰.桃红四物汤合瓜蒌薤白半夏汤治疗不稳定型心绞痛痰瘀互结证临床观察[J].四川中医,2025,43(02):134-137.
基金信息: